Logo for Addex Therapeutics Ltd

Addex Therapeutics Investor Relations Material

Latest events

Logo for Addex Therapeutics Ltd

Q3 2024

Addex Therapeutics
Logo for Addex Therapeutics

Q3 2024

22 Nov, 2024
Logo for Addex Therapeutics

H1 2024

30 Sep, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Addex Therapeutics Ltd

Access all reports
Addex Therapeutics Ltd is a biotechnology company focused on the discovery and development of small molecule therapies for neurological disorders. The company specializes in allosteric modulators, a drug discovery approach aimed at targeting specific receptors in the central nervous system to treat conditions such as Parkinson’s disease, epilepsy, and schizophrenia. Addex conducts clinical and preclinical research to advance its pipeline of investigational treatments. The company is headquartered in Geneva, Switzerland, and its shares are listed on the SIX Swiss Exchange.